Skysona Gets Accelerated Approval for Early, Active Cerebral Adrenoleukodystrophy
The FDA has approved Skysona to slow the progression of neurologic dysfunction in boys with cerebral adrenoleukodystrophy.
Source: empr.com
📰 Boxed Warning News
Page 40 - Boxed Warning News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Boxed Warning. Real-time updates on events, politics, business and more.
bluebird bio Receives FDA Accelerated Approval for SKYSONA® Gene Therapy for Early, Active Cerebral Adrenoleukodystrophy (CALD) - bluebird bio (NASDAQ:BLUE) - Press Release
SKYSONA is the first FDA approved therapy shown to slow the progression of neurologic dysfunction in boys with this devastating and fatal neurodegener
Source: wiredprnews.com
Mallinckrodt Receives U.S. FDA Approval for Terlivaz® (terlipressin) for injection for the Treatment of Hepatorenal Syndrome (HRS)
/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA)...
Source: prnewswire.com
Jazz Pharmaceuticals to Present Advancements in Sleep Medicine at Psych Congress 2022
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will present seven abstracts from across its neuroscience portfolio at...
Source: prnewswire.com
AbbVie to Present Data From its Robust Migraine Portfolio at the Migraine Trust International Symposium 2022
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that new data from its migraine portfolio will be presented at the Migraine Trust International Symposium...
Source: prnewswire.com
STUDY PUBLISHED IN EPILEPSIA SHOWS SIGNIFICANT PROLONGATION OF TIME INTERVALS BETWEEN SEIZURE CLUSTERS TREATED WITH NEURELIS' VALTOCO® (DIAZEPAM NASAL SPRAY) CIV
/PRNewswire/ -- Neurelis, Inc., announced the recent online publication of a novel data analysis, evaluating the time interval between seizure clusters, or...
Jurriaan Peters Craig Chambliss Brittany Bradrick Prnewswire Neurelis Inc Professor Of Neurology At Harvard Medical School Neurelis Inc
Source: prnewswire.com
Xenpozyme Approved for Acid Sphingomyelinase Deficiency
The FDA has approved Xenpozyme (olipudase alfa-rpcp) for non-CNS manifestations of acid sphingomyelinase deficiency in adult and pediatric patients.
Christine Nguyen Drug Administration Office Of Rare Diseases Boxed Warning Rare Diseases Reproductive Medicine
Source: empr.com
Y-mAbs and Takeda Announces Marketing Authorization in Israel for DANYELZA® (naxitamab-gqgk) for Neuroblastoma
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Data from Incyte's Dermatology Portfolio Accepted for Presentation at the 2022 European Academy of Dermatology and Venereology (EADV) Congress
Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from its dermatology portfolio will be presented at the upcoming 2022 European Academy of Dermatology and Venereology (EADV)
United States Catalina Loveman Christine Chiou Hidradenitis Suppurativa Jim Lee European Academy Of Dermatology
Source: finanznachrichten.de
Neurelis, Inc., Little Angels Service Dogs Present Aug. 25 "Barks 'n Blues Music & More" Concert to Build Epilepsy Awareness at Local Community Event
/PRNewswire/ -- Neurelis and Little Angels Service Dogs are proud to present the "Barks n Blues Music & More" concert for epilepsy awareness at the Quartyard,...
Source: prnewswire.com